CRB’s Horizons series of industry reports pools the talents and expertise of our leading subject matter experts to understand the conditions and forces affecting the life sciences and food and beverage industries. Based on hundreds of surveys of industry leaders, our free reports go deep on the critical trends driving the markets and how companies can stay on the leading edge.
HORIZONS
Horizons: Life Sciences
Our latest report, built on the insights of more than 500 life science industry leaders, explores the evolving science and business of drug manufacturing and the operational shifts our industry must make, especially as COVID-19 has changed our work and our world.
2021 Life Sciences Report
We explore the disruptive forces reshaping how biopharma companies speed life-saving therapies and vaccines to the market.
Read More
2021 Alternative Proteins Report
Growing demand for alternative proteins has manufacturers reconsidering everything from packaging and safety to regulation and project delivery.
Read More
2020 Cell & Gene Therapy Report
Through a survey of nearly 150 industry leaders, our inaugural CRB Horizons: Cell and Gene Therapy report finds the biopharma space at a critical inflection point.
Read More
